Literature DB >> 1483410

A quantitative description of components of in vitro morphometric change in the rat osteoclast model: relationships with cellular function.

M Zaidi1, A S Alam, V S Shankar, B E Bax, B S Moonga, P J Bevis, M Pazianas, C L Huang.   

Abstract

We describe the in vitro morphometric changes shown by rat osteoclasts that accompany their functional responses to the application of a range of regulatory agents of known physiological importance. We introduce a cellular motility parameter, mu, which was defined through a quantification of retraction-protrusion behaviour. This was used in conjunction with a net cell retraction, rho, which is derived from the change in total cell area following the application of an agent. These terms were used together for the description of cellular motility changes in response to specific cellular regulatory agents. The definition of retraction-protrusion was normalised against control cell area, to give a dimensionless variable independent of the net cell retraction. Thus, mutual terms present in either descriptor cancelled when the complementary parameter was held constant. Furthermore, the descriptor, mu remained time-invariant for extended intervals (around 20 min) even when rho was varying following cell introduction into culture. Interventions also with substances known to modify osteoclast function, were capable of altering each descriptor, to different extents. Thus elevation of the extracellular Ca2+ concentration ([Ca2+]e) at the osteoclast calcium "receptor" altered rho without changes in mu. In contrast, the polypeptide amylin (250 nM), within 20 minutes of application, elicited a marked change in mu, but only a relatively small change in rho. Finally, human calcitonin treatment (300 pM) influenced both descriptors. When combined together, these morphometric findings accordingly offer complementary descriptions of visible cellular changes in response to added agents of physiological relevance.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483410     DOI: 10.1007/bf00188348

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  7 in total

Review 1.  "Calcium receptors" on eukaryotic cells with special reference to the osteoclast.

Authors:  M Zaidi
Journal:  Biosci Rep       Date:  1990-12       Impact factor: 3.840

2.  Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways.

Authors:  M Zaidi; H K Datta; B S Moonga; I MacIntyre
Journal:  J Endocrinol       Date:  1990-09       Impact factor: 4.286

3.  'Calcium-activated' intracellular calcium elevation: a novel mechanism of osteoclast regulation.

Authors:  M Zaidi; H K Datta; A Patchell; B Moonga; I MacIntyre
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

4.  A quantitative analysis of alterations in the shape of cultured fibroblasts induced by tumour-promoting phorbol ester.

Authors:  A F Brown; V Dugina; G A Dunn; J M Vasiliev
Journal:  Cell Biol Int Rep       Date:  1989-04

5.  Modularity of osteoclast behaviour and "mode-specific" inhibition of osteoclast function.

Authors:  M Zaidi
Journal:  Biosci Rep       Date:  1990-12       Impact factor: 3.840

6.  Selective antagonism of calcitonin-induced osteoclastic quiescence (Q effect) by human calcitonin gene-related peptide-(Val8Phe37).

Authors:  A S Alam; B S Moonga; P J Bevis; C L Huang; M Zaidi
Journal:  Biochem Biophys Res Commun       Date:  1991-08-30       Impact factor: 3.575

7.  Alignment of fibroblasts on grooved surfaces described by a simple geometric transformation.

Authors:  G A Dunn; A F Brown
Journal:  J Cell Sci       Date:  1986-07       Impact factor: 5.285

  7 in total
  7 in total

Review 1.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

2.  Trabecular bone structure in patients with primary hyperparathyroidism.

Authors:  M Vogel; M Hahn; G Delling
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Predictors of COVID-19 Hospital Treatment Outcome.

Authors:  Ryszard Tomasiuk; Jan Dabrowski; Jolanta Smykiewicz; Magdalena Wiacek
Journal:  Int J Gen Med       Date:  2021-12-22

4.  CD38/ADP-ribosyl cyclase: A new role in the regulation of osteoclastic bone resorption.

Authors:  L Sun; O A Adebanjo; B S Moonga; S Corisdeo; H K Anandatheerthavarada; G Biswas; T Arakawa; Y Hakeda; A Koval; B Sodam; P J Bevis; A J Moser; F A Lai; S Epstein; B R Troen; M Kumegawa; M Zaidi
Journal:  J Cell Biol       Date:  1999-09-06       Impact factor: 10.539

5.  Mode of action of interleukin-6 on mature osteoclasts. Novel interactions with extracellular Ca2+ sensing in the regulation of osteoclastic bone resorption.

Authors:  O A Adebanjo; B S Moonga; T Yamate; L Sun; C Minkin; E Abe; M Zaidi
Journal:  J Cell Biol       Date:  1998-09-07       Impact factor: 10.539

6.  Serum C-reactive protein and procalcitonin kinetics in patients undergoing elective total hip arthroplasty.

Authors:  Sandra Battistelli; Mattia Fortina; Serafino Carta; Roberto Guerranti; Francesco Nobile; Paolo Ferrata
Journal:  Biomed Res Int       Date:  2014-05-04       Impact factor: 3.411

7.  Endogenous calcitonin regulates lipid and glucose metabolism in diet-induced obesity mice.

Authors:  Misa Nakamura; Sachiko Nomura; Tadashi Yamakawa; Ryohei Kono; Akihiro Maeno; Takashi Ozaki; Akitoshi Ito; Toyonobu Uzawa; Hirotoshi Utsunomiya; Kennichi Kakudo
Journal:  Sci Rep       Date:  2018-11-19       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.